Advertisement

Topics

Ligon Discovery Company Profile

01:13 EDT 21st September 2017 | BioPortfolio

Ligon Discovery is a Harvard University spinout that leverages a patented platform technology to identify pre-clinical drug candidates. The company's high-throughput microarray "chip" transforms the speed of the drug discovery process and expands the scope of new drug prospecting to include previously intractable targets. With funding from incTANK Ventures, the team has deployed the SMM technology, originally invented at Harvard University and further developed at the Broad Institute (founded by MIT and Harvard University) in Cambridge, and has established one of the largest small molecule screening capabilities in the industry. Using this facility, Ligon has successfully completed screens in the fields of coagulation and cancer, and is actively pursuing drug discovery in other areas of high unmet medical need. For more information, visit www.ligondiscovery.com.


News Articles [449 Associated News Articles listed on BioPortfolio]

Consortium Applies Quantum Computing to Drug Discovery for Neurological Diseases

NewsMolecular comparison is a crucial part of early-phase drug design and discovery.

Sygnature Discovery partners on pancreatic cancer research

Sygnature Discovery, which claims to be the UK’s largest independent drug discovery expert and research…

Target class drug discovery

Selection of molecular targets based on disease understanding is a dominant paradigm in drug discovery. We argue that a focus on classes of targets with central roles in biology provides a complimenta...

Almac Discovery y Debiopharm International SA anuncian el desarrollo de un nuevo inhibidor Wee-1

Almac Discovery ( http://www.almacgroup.com/discovery), una compañía biofarmacéutica centrada en el descubrimiento e identificación de terapéuticos innovadores para el tratamiento del cáncer, ...

Dementia Discovery Fund to invest $5m in Cerevance to advance Alzheimer’s treatment

SV Life Sciences-managed Dementia Discovery Fund (DDF), which develops disease modifying drugs for dementia, has announced a $5m investment in the initial financing round of start-up drug discovery co...

BioAscent Discovery Appoints New CEO And Announces Plans To Expand Discovery Services Offering

  Life Sciences Jobs   ...

Daiichi Sankyo in Drug Discovery Collaboration

Enters cancer research partnership with Max Planck Innovation and Lead Discovery Center

Zealand, Orbit Discovery enter into research collaboration

Zealand Pharma and Orbit Discovery have entered into a multi-target research collaboration to identify novel peptide therapeutics using Orbit’s proprietary peptide display technology. Zealand ha...

PubMed Articles [682 Associated PubMed Articles listed on BioPortfolio]

Genome-wide analysis of gene expression of EMS-induced short fiber mutant Ligon lintless-y (liy) in cotton (Gossypium hirsutum L.).

In this work we describe a chemically-induced short fiber mutant cotton line, Ligon-lintless-y (liy), which is controlled by a single recessive locus and affects multiple traits, including height of t...

Role of Academic Drug Discovery in the Quest for New CNS Therapeutics.

There was a greater than 50% decline in central nervous system (CNS) drug discovery and development programs by major pharmaceutical companies from 2009 to 2014. This decline was paralleled by a rise ...

Advances in epilepsy gene discovery and implications for epilepsy diagnosis and treatment.

Epilepsy genetics is shifting from the academic pursuit of gene discovery to a clinical discipline based on molecular diagnosis and stratified medicine. We consider the latest developments in epilepsy...

The Utility of Target-Based Discovery.

18F-FDG silicon photomultiplier PET/CT: A pilot study comparing semi-quantitative measurements with standard PET/CT.

To evaluate if the new Discovery Molecular Insights (DMI) PET/CT scanner provides equivalent results compared to the standard of care PET/CT scanners (GE Discovery 600 or GE Discovery 690) used in our...

Clinical Trials [137 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Endometriosis Biomarker Discovery Study

This is a prospective, Single time point, discovery study intending to identify biomarkers that can differentiate endometriosis from other underlying reasons for pelvic pain. Patients unde...

Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma

The purpose of the study is to better understand the function of asthma and COPD, and response to therapy. There are two Phases to this study broken into two arms. In Phase I, our propose ...

Retrospective Study on the Evaluation of Intra-disc Infiltration in the Active Disc Disease

Active discopathies or MODIC 1, are a diagnostic entity discovery with the contribution of MRI in which the first cases were described by Dr. Michael MODIC in 1988. It is characterized by ...

Companies [1059 Associated Companies listed on BioPortfolio]

Ligon Discovery

Ligon Discovery is a Harvard University spinout that leverages a patented platform technology to identify pre-clinical drug candidates. The company's high-throughput microarray "chip" transforms the s...

Ligon Discovery, Inc.

Discovery Health

Discovery Health Media includes the Discovery Health and FitTV television networks and online assets, including www.discoveryhealth.com, as well as its Continuing Medical Education (CME) business and ...

Argenta Discovery Ltd.

Argenta Discovery is a privately held drug discovery company, applying its integrated medicinal chemistry, biology, ADMET and CADD expertise to drive drug discovery programmes. Argenta has a successfu...

Pyxis Discovery B.V.

The ambition of Pyxis Discovery is to be the preferred chemistry service provider for companies that are active in small molecule drug discovery. Pyxis Discovery's Smart approach of designing and ...

More Information about "Ligon Discovery" on BioPortfolio

We have published hundreds of Ligon Discovery news stories on BioPortfolio along with dozens of Ligon Discovery Clinical Trials and PubMed Articles about Ligon Discovery for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ligon Discovery Companies in our database. You can also find out about relevant Ligon Discovery Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record